SCHEMBL1534415

SCHEMBL1534415

Nc1ccc2c(=O)c(Br)c(-c3ccccc3)oc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DDR2 Q16832 1/20 0.51
KDM4E B2RXH2 5/20 0.50
MEN1 O00255 5/20 0.50
KMT2A Q03164 5/20 0.50
CYP3A4 P08684 4/20 0.50
MAPT P10636 4/20 0.50
HSD17B10 Q99714 3/20 0.50
ALOX15 P16050 2/20 0.50
CASP1 P29466 2/20 0.50
CASP7 P55210 2/20 0.50
ALDH1A1 P00352 4/20 0.48
CYP2C9 P11712 1/20 0.48
TSHR P16473 1/20 0.48
CYP2C19 P33261 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
HPGD P15428 3/20 0.46
THRB P10828 1/20 0.46
BCHE P06276 1/20 0.45
ACHE P22303 1/20 0.45
CA1 P00915 5/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11237027 0.82 ALDH1A1 (0.70) DDR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL27952154 0.82 CYP3A4 (0.74) KDM4EMEN1KMT2ACYP3A4MAPT
SCHEMBL1534666 0.81 KMT2A (0.65) DDR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL29501080 0.81 KMT2A (0.65) DDR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL16332352 0.76 ALDH1A1 (0.51) DDR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL28158806 0.75 KDM4E (0.50) DDR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL9952260 0.75 KDM4E (0.50) DDR2KDM4EMEN1KMT2ACYP3A4
SCHEMBL27940011 0.73 KDM4E (0.60) KDM4EMEN1KMT2ACYP3A4MAPT
SCHEMBL31613986 0.73 RAB9A (0.69) KDM4EMEN1KMT2ACYP3A4MAPT
SCHEMBL1937499 0.73 RAB9A (0.69) KDM4EMEN1KMT2ACYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8546376-B2 Pharmaceutical compounds ALMAC DISCOVERY LIMITED (GB) 2013-10-01 US disclosed
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2012-09-20 US disclosed
EP-2473495-A1 PHARMACEUTICAL COMPOUNDS Almac Discovery Limited (GB) 2012-07-11 EP disclosed
WO-2011033265-A1 PHARMACEUTICAL COMPOUNDS ALMAC DISCOVERY LIMITED (GB) 2011-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238541-A1 PHARMACEUTICAL COMPOUNDS PIK3CA, PLK1, MTOR DDR2 1548/4885KDM4E 1952/4885MEN1 645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.